Maintenance inhalers for COPD and asthma on every 2026 Puerto Rico Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 3 stand-alone Part D plans in Puerto Rico cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | HealthSpring Extra Rx$50.00/moS5617-385 | HealthSpring Assurance Rx$65.70/moS5617-348 | AARP Medicare Rx Preferred from UHC$145.10/moS5820-037 |
|---|---|---|---|
| Trelegy Elliptafluticasone/umeclidinium/vilanterol | Tier 317%QL 60/30d | Tier 322%QL 60/30d | Tier 325%QL 60/30d |
| Breztri Aerospherebudesonide/glycopyrrolate/formoterol | Not covered | Not covered | Tier 325%QL 10.7/30d |
| Anoro Elliptaumeclidinium/vilanterol | Tier 317%QL 60/30d | Tier 322%QL 60/30d | Tier 325%QL 60/30d |
| Stiolto Respimattiotropium/olodaterol | Not covered | Not covered | Tier 325%QL 4/30d |
| Spirivatiotropium | Tier 4ST31%QL 4/30d | Tier 4ST34%QL 4/30d | Tier 325%QL 30/30d |
| Incruse Elliptaumeclidinium | Tier 317%QL 30/30d | Tier 322%QL 30/30d | Tier 325%QL 30/30d |
| Breo Elliptafluticasone/vilanterol | Tier 317%QL 60/30d | Tier 322%QL 60/30d | Tier 325%QL 60/30d |
| Symbicortbudesonide/formoterol | Not covered | Not covered | Tier 325%QL 10.2/30d |
| budesonide-formoterolgeneric Symbicort | Not covered | Not covered | Not covered |
| Advairfluticasone/salmeterol | Tier 317%QL 12/30d | Tier 322%QL 12/30d | Not covered |
| Wixela Inhubfluticasone/salmeterol, generic Advair | Not covered | Not covered | Tier 325%QL 60/30d |
| Duleramometasone/formoterol | Not covered | Not covered | Tier 425%QL 13/30d |
| Arnuity Elliptafluticasone furoate | Tier 317%QL 30/30d | Tier 322%QL 30/30d | Tier 325%QL 30/30d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.